Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Margolin

Showing results (31-40 of 96) with videos related to

Pageof 10
Sort By:
JAMA Oncology|April 6, 2018
Management of Metastatic Melanoma in 2018Howard L Kaufman, Kim Margolin, Ryan Sullivan
Journal of Translational Medicine|January 30, 2009
Summary of the primer on tumor immunology and the biological therapy of cancerYufeng Li, Shujuan Liu, Kim Margolin, et al.
Case Reports in Oncological Medicine|May 17, 2019
Fulminant Disseminated Intravascular Coagulation as Initial Presentation of BRAF-Mutated MelanomaJeremy Chuang, An Uche, Rohan Gupta, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 4, 2020
And Now for Something Completely Different: Immunotherapy Beyond Checkpoints in MelanomaIsabella Claudia Glitza, Stephanie L Goff, Merrick Ross, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Modern Management of Central Nervous System Metastases in the Era of Targeted Therapy and Immune OncologyPriscilla Brastianos, Michael A Davies, Kim Margolin, et al.
Cancers|December 17, 2024
Evaluating the Safety of Immune Checkpoint Inhibitors and Combination Therapies in the Management of Brain Metastases: A Comprehensive ReviewVivek Podder, Tulika Ranjan, Kim Margolin, et al.
Clinical Genitourinary Cancer|July 25, 2006
A phase II study of depsipeptide in refractory metastatic renal cell cancerWalter M Stadler, Kim Margolin, Sandy Ferber, et al.
Cancers|October 16, 2024
Immune Checkpoint Inhibitors in the Management of Brain Metastases from Non-Small Cell Lung Cancer: A Comprehensive Review of Current Trials, Guidelines and Future DirectionsTulika Ranjan, Vivek Podder, Kim Margolin, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Advances in the Treatment of Advanced Extracutaneous Melanomas and Nonmelanoma Skin CancersKimberly M Komatsubara, Joanne Jeter, Richard D Carvajal, et al.
Cells|October 14, 2022
Next Generation Immuno-Oncology Strategies: Unleashing NK Cells ActivityAlberto Mendoza-Valderrey, Maite Alvarez, Andrea De Maria, et al.
Pageof 10

Showing results (31-40 of 96) with videos related to

Sort By:
Pageof 10
JAMA Oncology|April 6, 2018
Management of Metastatic Melanoma in 2018Howard L Kaufman, Kim Margolin, Ryan Sullivan
Journal of Translational Medicine|January 30, 2009
Summary of the primer on tumor immunology and the biological therapy of cancerYufeng Li, Shujuan Liu, Kim Margolin, et al.
Case Reports in Oncological Medicine|May 17, 2019
Fulminant Disseminated Intravascular Coagulation as Initial Presentation of BRAF-Mutated MelanomaJeremy Chuang, An Uche, Rohan Gupta, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 4, 2020
And Now for Something Completely Different: Immunotherapy Beyond Checkpoints in MelanomaIsabella Claudia Glitza, Stephanie L Goff, Merrick Ross, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Modern Management of Central Nervous System Metastases in the Era of Targeted Therapy and Immune OncologyPriscilla Brastianos, Michael A Davies, Kim Margolin, et al.
Cancers|December 17, 2024
Evaluating the Safety of Immune Checkpoint Inhibitors and Combination Therapies in the Management of Brain Metastases: A Comprehensive ReviewVivek Podder, Tulika Ranjan, Kim Margolin, et al.
Clinical Genitourinary Cancer|July 25, 2006
A phase II study of depsipeptide in refractory metastatic renal cell cancerWalter M Stadler, Kim Margolin, Sandy Ferber, et al.
Cancers|October 16, 2024
Immune Checkpoint Inhibitors in the Management of Brain Metastases from Non-Small Cell Lung Cancer: A Comprehensive Review of Current Trials, Guidelines and Future DirectionsTulika Ranjan, Vivek Podder, Kim Margolin, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Advances in the Treatment of Advanced Extracutaneous Melanomas and Nonmelanoma Skin CancersKimberly M Komatsubara, Joanne Jeter, Richard D Carvajal, et al.
Cells|October 14, 2022
Next Generation Immuno-Oncology Strategies: Unleashing NK Cells ActivityAlberto Mendoza-Valderrey, Maite Alvarez, Andrea De Maria, et al.
Pageof 10